Tumor expression of adiponectin receptor 2 and lethal prostate cancer.
暂无分享,去创建一个
Jennifer R. Rider | M. Loda | E. Giovannucci | M. Fiorentino | T. Gerke | L. Mucci | R. Kelly | J. Sinnott | S. Finn | K. Jordahl | Kristina M. Jordahl
[1] J. Tanus-Santos,et al. Adiponectin ‐11377C/G and +276G/T Polymorphisms affect Adiponectin Levels but do not Modify Responsiveness to Therapy in Resistant Hypertension , 2015, Basic & clinical pharmacology & toxicology.
[2] Zhongming Jia,et al. Adiponectin Induces Breast Cancer Cell Migration and Growth Factor Expression , 2014, Cell Biochemistry and Biophysics.
[3] S. Gapstur,et al. No Association of Plasma Levels of Adiponectin and c-peptide with Risk of Aggressive Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[4] M. Loda,et al. Dietary lycopene, angiogenesis, and prostate cancer: a prospective study in the prostate-specific antigen era. , 2014, Journal of the National Cancer Institute.
[5] P. Scherer,et al. Ronning After the Adiponectin Receptors , 2013, Science.
[6] K. Matsuda,et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity , 2013, Nature.
[7] D. Park,et al. Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression , 2013, Journal of Cancer Research and Clinical Oncology.
[8] M. Touvier,et al. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study. , 2013, American journal of epidemiology.
[9] Ming-jun Li,et al. Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis , 2013, Tumor Biology.
[10] Chien-Liang Liu,et al. Expression and Biologic Significance of Adiponectin Receptors in Papillary Thyroid Carcinoma , 2013, Cell Biochemistry and Biophysics.
[11] S. Wiltshire,et al. A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin, type 2 diabetes, insulin resistance and the metabolic syndrome , 2013, BMC Medical Genetics.
[12] T. Spector,et al. Common variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/2), adiponectin concentrations, and diabetes incidence in the Diabetes Prevention Program , 2012, Diabetic medicine : a journal of the British Diabetic Association.
[13] H. Randeva,et al. Protective Actions of Globular and Full-Length Adiponectin on Human Endothelial Cells: Novel Insights into Adiponectin-Induced Angiogenesis , 2012, Journal of Vascular Research.
[14] H. Nagawa,et al. Adiponectin receptor 2 is negatively associated with lymph node metastasis of colorectal cancer. , 2012, Oncology letters.
[15] J. Pinthus,et al. Adiponectin inhibits oxidative stress in human prostate carcinoma cells , 2012, Prostate Cancer and Prostatic Diseases.
[16] C. Mantzoros,et al. Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. , 2011, Metabolism: clinical and experimental.
[17] P. Nelson,et al. Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1. , 2011, Cancer cell.
[18] Jing Ma,et al. Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[19] Nengjun Yi,et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. , 2011, Metabolism: clinical and experimental.
[20] Jung-Hye Choi,et al. Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal Carcinoma In Situ and Invasive Breast Cancer , 2011, Journal of breast cancer.
[21] Jin-Ho Kim,et al. Adiponectin and adiponectin receptor in relation to colorectal cancer progression , 2010, International journal of cancer.
[22] M. Loda,et al. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Hirokazu Takahashi,et al. Molecular Mechanisms Linking Adiponectin Receptor Signalling and Cancer , 2010 .
[24] P. Beddy,et al. Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinoma , 2010, The British journal of surgery.
[25] M. Stampfer,et al. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. , 2010, Clinical chemistry.
[26] Chih-Hsin Tang,et al. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF‐κB pathways , 2009, The Prostate.
[27] Stacey A. Kenfield,et al. Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] Jing Ma,et al. Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] D. Mozaffarian,et al. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. , 2008, Clinical chemistry.
[30] R. Considine,et al. Adiponectin and Leptin in African Americans , 2008, Obesity.
[31] E. Barrett-Connor,et al. Adiponectin and Ghrelin Levels and Body Size in Normoglycemic Filipino, African‐American, and White Women , 2007, Obesity.
[32] P. Froguel,et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.
[33] C. Mantzoros,et al. Serum Adiponectin Concentrations and Tissue Expression of Adiponectin Receptors Are Reduced in Patients with Prostate Cancer: A Case Control Study , 2007, Cancer Epidemiology Biomarkers & Prevention.
[34] C. Mantzoros,et al. Adiponectin and cancer: a systematic review , 2006, British Journal of Cancer.
[35] J. Bub,et al. Adiponectin as a growth inhibitor in prostate cancer cells. , 2006, Biochemical and biophysical research communications.
[36] B. Gower,et al. Adiponectin is lower among African Americans and is independently related to insulin sensitivity in children and adolescents. , 2005, Diabetes.
[37] Jun Luo,et al. Trefoil factor 3 overexpression in prostatic carcinoma: Prognostic importance using tissue microarrays , 2004, The Prostate.
[38] E. Ravussin,et al. Adiponectin receptors gene expression and insulin sensitivity in non-diabetic Mexican Americans with or without a family history of Type 2 diabetes , 2004, Diabetologia.
[39] S. Kihara,et al. Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.
[40] M. Cnop,et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.
[41] E. Rimm,et al. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. , 2003, Clinical chemistry.
[42] S. Uchida,et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature Medicine.
[43] P. Scherer,et al. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism , 2002, Trends in Endocrinology & Metabolism.
[44] G. Bray,et al. Differential expression of leptin receptor in high- and low-fat-fed Osborne-Mendel and S5B/Pl rats. , 2000, Obesity research.
[45] C. Hennekens,et al. Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. , 2000, Annals of epidemiology.
[46] D. Allred,et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[47] J. Manson,et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. , 1996, The New England journal of medicine.
[48] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[49] Final report on the aspirin component of the ongoing Physicians' Health Study. , 1989, The New England journal of medicine.
[50] D. Neville,et al. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. , 1974, Proceedings of the National Academy of Sciences of the United States of America.